TRENTINI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 5.870
EU - Europa 1.958
AS - Asia 928
OC - Oceania 11
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 5
Totale 8.788
Nazione #
US - Stati Uniti d'America 5.857
IT - Italia 592
CN - Cina 566
PL - Polonia 435
UA - Ucraina 243
DE - Germania 214
TR - Turchia 209
GB - Regno Unito 151
SE - Svezia 85
FI - Finlandia 68
HK - Hong Kong 54
IE - Irlanda 41
BE - Belgio 34
VN - Vietnam 27
FR - Francia 26
ES - Italia 14
KR - Corea 13
IR - Iran 12
CA - Canada 11
SG - Singapore 11
AT - Austria 9
NL - Olanda 9
RO - Romania 9
AU - Australia 8
SD - Sudan 7
TW - Taiwan 7
IN - India 6
MY - Malesia 6
CZ - Repubblica Ceca 5
JP - Giappone 5
EU - Europa 4
ID - Indonesia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
HR - Croazia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BR - Brasile 2
DK - Danimarca 2
EG - Egitto 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
TH - Thailandia 1
Totale 8.788
Città #
Fairfield 776
Woodbridge 701
Ann Arbor 492
Chandler 452
Warsaw 419
Ashburn 418
Houston 412
Jacksonville 316
Ferrara 280
Seattle 277
Wilmington 260
Cambridge 251
Izmir 156
Beijing 126
Nanjing 120
Princeton 115
Menlo Park 98
Boardman 75
Milan 68
Shanghai 65
Dearborn 55
Hong Kong 52
San Diego 52
Addison 48
Nanchang 39
Bremen 37
Shenyang 37
Brussels 33
New York 32
Dong Ket 27
Falls Church 26
Bologna 23
Changsha 23
Tianjin 23
Jiaxing 21
Los Angeles 20
Hebei 18
Redwood City 18
Norwalk 16
London 15
Ningbo 15
Orange 15
Washington 14
Mountain View 12
St Louis 12
Jinan 11
Auburn Hills 10
Augusta 10
Rome 10
Guangzhou 9
Hefei 9
Kraków 9
Vienna 9
Casalecchio Di Reno 8
Des Moines 8
Leawood 8
Montréal 8
Munich 8
San Mateo 8
Chicago 7
Helsinki 7
Indiana 7
Taizhou 7
Zhengzhou 7
Ferrara di Monte Baldo 6
Kunming 6
Singapore 6
Tappahannock 6
Cagliari 5
Kilburn 5
Lübeck 5
Wageningen 5
Khartoum 4
Lanzhou 4
Monmouth Junction 4
Padova 4
Philadelphia 4
Shah Alam 4
Taipei 4
Wuhan 4
Berlin 3
Calderara Di Reno 3
Dublin 3
Haikou 3
Hangzhou 3
Lappeenranta 3
Melbourne 3
Modena 3
Paris 3
Redmond 3
Sofia 3
Tokyo 3
Villafranca Padovana 3
Adelfia 2
Ardabil 2
Cagayan de Oro 2
Castelliri 2
Dolo 2
Durham 2
Edinburgh 2
Totale 6.849
Nome #
Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease 221
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 183
Gelatinases, Neurofilaments and N-Acetyl aspartic Acid as Biomarkers in Different Pathologies 173
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 168
null 163
Influence of Vaginal Lactoferrin Administration on Amniotic Fluid Cytokines and its Role Against Inflammatory Complications of Pregnancy 159
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 154
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 146
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 143
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 139
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 136
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia 134
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 130
Extrapulmonary tuberculosis among immigrants in a low-TB burden and high immigrant receiving city of northern Italy 129
null 128
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 127
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 123
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 121
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 120
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women 119
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 116
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 113
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 113
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 112
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 112
Study of the potential influence of obesity on the activities of serum Paraoxonase-1 and lipoprotein-associated phospholipase A2 111
null 110
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 110
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 109
Leptin/adiponectin ratio predicts post-stroke neurological outcome 109
null 106
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 106
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 105
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 105
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 100
Proteomic analysis of 4-hydroxynonenal and nitrotyrosine modified proteins in RTT fibroblasts 100
Serum from patients affected by Alzheimer disease shows a paraoxonase-dependent pro-apoptotic effect on endothelial cells 100
null 97
Epidemiologia ed Outcome delle Infezioni della Cute e dei Tessuti Molli Osservate a Ferrara nel Quinquennio 2011-2016 90
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 87
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 86
null 86
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 86
null 85
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 84
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 84
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 84
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 84
null 83
Evaluation of a possible role of oxidative stress in climacteric symptoms. 83
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 82
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 81
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 81
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease 80
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 79
null 78
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 78
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 76
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 76
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 76
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 70
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 70
Implication of oxidative stress in dementia: data from cross-sectional and longitudinal study 69
null 68
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 66
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 65
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 63
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 62
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 61
EVALUATION OF THE SWITCH TO A DUAL ART REGIMEN WITH LAMIVUDINE PLUS DOLUTEGRAVIR OR PROTEASE INHIBITORS IN HIV-INFECTED VIROLOGICALLY SUPPRESSED PATIENTS. A REAL LIFE EXPERIENCE 61
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 61
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 61
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 60
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study 56
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 56
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 55
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 55
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 55
Purification of transglutaminase enzyme from L. infantum promastigotes 54
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 54
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 53
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 53
Diaphragmatic dysfunction in critically patients undergoing mechanical ventilation 51
Clinical and Laboratory Findings in Tick-Borne Encephalitis Virus Infection 51
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 49
null 49
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 49
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 46
null 44
MMP-9 isoforms in serum of Multiple Sclerosis patients 41
The influence of different replacement solutions on neutrophils response 41
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: Insights from EVA study 40
Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis 37
Inflammation in Neurological Disorders: The Thin Boundary between Brain and Periphery 35
Tuberculosis Epidemiology and Drug Resistance Among Immigrants and Natives in a City of Northern Italy 32
Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review 31
Sex and gender differences in ischemic heart disease: endocrine vascular disease approach (EVA) study design 30
Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia 28
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 27
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 24
Totale 8.692
Categoria #
all - tutte 38.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.960


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019385 0 0 0 0 0 0 0 0 0 0 0 385
2019/20201.877 287 70 53 238 115 207 211 190 189 171 86 60
2020/20211.782 106 110 94 154 162 164 102 185 89 310 181 125
2021/20221.247 100 145 155 42 41 75 61 71 37 113 58 349
2022/20231.137 119 104 35 135 174 146 72 111 125 9 65 42
2023/2024667 67 84 37 24 94 98 42 78 44 33 43 23
Totale 9.137